These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 19514426)

  • 1. [The role of thyroid hypofunction in development of metabolic syndrome].
    Demidova TIu; Galieva OR
    Ter Arkh; 2009; 81(4):69-73. PubMed ID: 19514426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Selected Atherosclerosis Risk Factors in Women with Subclinical Hypothyroidism Treated with L-Thyroxine.
    Adamarczuk-Janczyszyn M; Zdrojowy-Wełna A; Rogala N; Zatońska K; Bednarek-Tupikowska G
    Adv Clin Exp Med; 2016; 25(3):457-63. PubMed ID: 27629733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between metabolic syndrome, serum thyrotropin, and thyroid antibodies status in postmenopausal women, and the role of interleukin-6.
    Siemińska L; Wojciechowska C; Walczak K; Borowski A; Marek B; Nowak M; Kajdaniuk D; Foltyn W; Kos-Kudła B
    Endokrynol Pol; 2015; 66(5):394-403. PubMed ID: 26457493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclinical hypothyroidism, lipid metabolism and cardiovascular disease.
    Delitala AP; Fanciulli G; Maioli M; Delitala G
    Eur J Intern Med; 2017 Mar; 38():17-24. PubMed ID: 28040402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid hormone replacement for central hypothyroidism: a randomized controlled trial comparing two doses of thyroxine (T4) with a combination of T4 and triiodothyronine.
    Slawik M; Klawitter B; Meiser E; Schories M; Zwermann O; Borm K; Peper M; Lubrich B; Hug MJ; Nauck M; Olschewski M; Beuschlein F; Reincke M
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4115-22. PubMed ID: 17711927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The different requirement of L-T4 therapy in congenital athyreosis compared with adult-acquired hypothyroidism suggests a persisting thyroid hormone resistance at the hypothalamic-pituitary level.
    Bagattini B; Cosmo CD; Montanelli L; Piaggi P; Ciampi M; Agretti P; Marco GD; Vitti P; Tonacchera M
    Eur J Endocrinol; 2014 Nov; 171(5):615-21. PubMed ID: 25305309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 18 months of L-T4 replacement in women with subclinical hypothyroidism.
    Adrees M; Gibney J; El-Saeity N; Boran G
    Clin Endocrinol (Oxf); 2009 Aug; 71(2):298-303. PubMed ID: 19094068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological functions and metabolic aspects in subclinical hypothyroidism: the effects of L-thyroxine.
    Baldini M; Colasanti A; Orsatti A; Airaghi L; Mauri MC; Cappellini MD
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(5):854-9. PubMed ID: 19389454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Obesity and hypothyroidism: myth or reality?].
    Portmann L; Giusti V
    Rev Med Suisse; 2007 Apr; 3(105):859-62. PubMed ID: 17514926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of type II deiodinase polymorphisms in clinical management of hypothyroid patients treated with levothyroxine.
    Al-azzam SI; Alkhateeb AM; Al-Azzeh O; Alzoubi KH; Khabour OF
    Exp Clin Endocrinol Diabetes; 2013 May; 121(5):300-5. PubMed ID: 23329579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The incidence of hypothyroidism symptoms and risk factors for cardiovascular events in subclinical hypothyroidism].
    Krysicki M; Jaworska M; Popowicz B; Jankiewicz-Wika J; Klencki M; Słowińska-Klencka D
    Pol Merkur Lekarski; 2014 Jul; 37(217):10-6. PubMed ID: 25154193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of L-thyroxine replacement therapy on lipid based cardiovascular risk in subclinical hypothyroidism.
    Serter R; Demirbas B; Korukluoglu B; Culha C; Cakal E; Aral Y
    J Endocrinol Invest; 2004 Nov; 27(10):897-903. PubMed ID: 15762035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aerobic exercise training on serum sex hormone binding globulin, body fat index, and metabolic syndrome factors in obese postmenopausal women.
    Kim JW; Kim DY
    Metab Syndr Relat Disord; 2012 Dec; 10(6):452-7. PubMed ID: 22989086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the relationship between subclinical hypothyroidism and metabolic syndrome components among workers.
    Cheserek MJ; Wu G; Shen L; Shi Y; Le G
    Int J Occup Med Environ Health; 2014 Apr; 27(2):175-87. PubMed ID: 24619737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Hypothyroidism with Body Mass Index, Systolic Blood Pressure and Proteinuria in Diabetic Patients: Does treated Hypothyroidism with Thyroxine Replacement Therapy Prevent Nephropathy/Chronic Renal Disease?
    Aziz KM
    Curr Diabetes Rev; 2016; 12(3):297-306. PubMed ID: 26511212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of elevated thyroid-stimulating hormone levels in polycystic ovary syndrome.
    Trummer C; Schwetz V; Giuliani A; Obermayer-Pietsch B; Lerchbaum E
    Gynecol Endocrinol; 2015 Oct; 31(10):819-23. PubMed ID: 26190535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of hypothyroidism occurring in patients with metabolic syndrome.
    Gierach M; Junik R
    Endokrynol Pol; 2015; 66(4):288-94. PubMed ID: 26323464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study).
    Meier C; Staub JJ; Roth CB; Guglielmetti M; Kunz M; Miserez AR; Drewe J; Huber P; Herzog R; Müller B
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4860-6. PubMed ID: 11600554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal thyroxine and elevated thyrotropin concentrations: evolving hypothyroidism or persistent euthyroidism with reset thyrostat.
    Kabadi UM; Cech R
    J Endocrinol Invest; 1997 Jun; 20(6):319-26. PubMed ID: 9294777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central hypothyroidism and its replacement have a significant influence on cardiovascular risk factors in adult hypopituitary patients.
    Klose M; Marina D; Hartoft-Nielsen ML; Klefter O; Gavan V; Hilsted L; Rasmussen AK; Feldt-Rasmussen U
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3802-10. PubMed ID: 23796569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.